Maxtra Global Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-07-2024
- Paid Up Capital ₹ 0.40 M
as on 07-07-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.15 Cr
as on 07-07-2024
- Revenue 33.25%
(FY 2021)
- Profit 33.17%
(FY 2021)
- Ebitda -393.25%
(FY 2021)
- Net Worth 37.52%
(FY 2021)
- Total Assets 88.92%
(FY 2021)
About Maxtra Global
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹3.15 Cr.
Abhijeet Motiwale, Hemant Mehta, Amit Chawla, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MP2016PTC042065
- Company No.
042065
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Dec 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Maxtra Global?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharan Simon  | Director | 26-Dec-2016 | Current |
| Abhijeet Motiwale | Director | 26-Dec-2016 | Current |
| Hemant Mehta | Director | 26-Dec-2016 | Current |
| Amit Chawla | Director | 26-Dec-2016 | Current |
Financial Performance and Corporate Structure Insights of Maxtra Global.
Maxtra Global Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 33.25% increase. The company also saw a substantial improvement in profitability, with a 33.17% increase in profit. The company's net worth Soared by an impressive increase of 37.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maxtra Global?
In 2021, Maxtra Global had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
M C W Pharma Pvt LtdActive 36 years 5 monthsAbhijeet Motiwale, Amit Chawla and 1 more are mutual person
- Mcw Healthcare Private LimitedActive 24 years 8 months
Abhijeet Motiwale, Amit Chawla and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 22 May 2023 | ₹1.50 M | Open |
Bank Of India Creation Date: 22 Dec 2021 | ₹3.00 Cr | Open |
How Many Employees Work at Maxtra Global?
Unlock and access historical data on people associated with Maxtra Global, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxtra Global, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxtra Global's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
